Commission Regulation (EU) 2026/876 of 21 April 2026 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, aclonifen, deltamethrin, oxathiapiprolin and potassium phosphonates in or on certain products

Type Regulation
Publication 2026-04-21
State Repealed
Department European Commission, SANTE
Source EUR-Lex
Reform history JSON API

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.